Page 259

Confidentiality, 46, 100, 137 contact investigation, 106, 116 Contacts and contact investigation, 8, 9, 20, 37, 57, 86-87, 88, 101-117, 198 AIDS patients, 102, 104, 105, 111-115 (passim), 117 CDC role, 101, 106, 109, 111, 113, 114 children, 38, 102, 103, 110, 112, 116, 117, 119 confidentiality, 106, 116 costs, 103, 104, 116 cultural factors, 88, 104, 112-113, 115, 116 drug treatment for contacts, 89, 102, 106-107, 114, 117 funding, 103, 107-108, 113, 183, 198 health departments, 102, 103-108, 114, 116 immigrants, 102, 106, 111 incidence and, 103, 107-108, 114 multidrug-resistant tuberculosis, 102 patient education and, 112-113 private providers, 108-110 professional education for, 103, 106, 109-110, 111-112, 116 skin testing, 103, 106, 113, 114 standards, 110-111, 112 state government, 105, 107-108, 110 Correctional populations, ix, 8, 9, 27, 29, 31, 33, 70, 87, 88, 97, 99-101, 190, 197 incidence, 99 legal issues, 97, 99-101 multidrug resistance, 99, 100 skin testing, 9, 87, 88, 100-101 Cost factors, see Economic factors Cultural factors, see Social and cultural factors CURE-TB Binational Referral System, 154-155, 195 Cycloserine, 244

D

Dahlem Conference, 44 Databases contact investigation, 111 National Practitioner Data Bank, 62 public health data systems, 6, 52, 224 registries, 25, 27, 187-188, 196 see also Information management systems Demographic factors historical epidemiology, 13-14 see also Children; Correctional populations ; Homeless persons; Immigration and immigrants; Migrant and seasonal workers; Minority groups; Rural areas; Urban areas Department of Agriculture, 25 Department of Health and Human Services, 12, 130, 160, 165 Food and Drug Administration, 10, 128, 142-143, 213, 244, 245 Occupational Safety and Health Administration (OSHA), 203 Public Health Service, 14, 64, 133, 164 see also Centers for Disease Control and Prevention ; National Institutes of Health Department of State, see Agency for International Development ; Immigration and Naturalization Service Developing countries, 15, 23, 46, 48, 150-151, 227-228, 236-237 see also specific countries Diagnosis, 7, 16-17, 53, 55, 56, 65-66, 186-187, 205, 207-229 Amplified Direct Test (Gen-Probe), 212-213, 225 BACTEC system, 206, 207, 212, 216, 217-218, 225, 229 costs, 9, 56, 69-70, 77, 225 immigrants, 9, 56, 69-70, 77, 91, 92, 93-94, 95, 225, 239, 242 DNA techniques, 17, 38, 105, 115, 124-125, 214-215, 229 ethical issues, 46-48 FDA approved, 213 funding, 37, 52 global markets, 10-11, 155-156 high performance liquid chromatography, 211-212, 229 information management systems, 212 latent tuberculosis, 18, 46-47, 124-126, 144, 213 DNA techniques, 17, 38, 105, 115, 124-125, 214-215, 229 radiometric techniques, 124, 206, 207, 212, 216, 217-218, 225, 229 RNA techniques, 17, 213 see also Tuberculin skin testing LCx assay, 212, 213


The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement